JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
* Ficicioglu C et al. (2009) Cytokine and nitric oxide concentrations in follicular fluid and blood serum of patients undergoing assisted reproductive treatment: relationship to outcome. J Turkish-German Gynecol Assoc 2009; 10: 132-6 * Eroglu H et al. (2010) A Quadruped Study on Chitosan Microspheres Containing Atorvastatin Calcium: Preparation, Characterization, Quantification and in-Vivo Application. Chem Pharm Bull (Tokyo) 58:1161-1167 * Ficicioglu C et al. (2010) Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols. Gynecol Endocrinol. 26:181-186 * Cigdem B et al. (2012) Association of autonomic nervous system functions with immune response and prognosis. Cumhuriyet Med J 34: 416-422 * Saleh OS et al. (2013) Protective effects of propolis on gammairradiated nigella sativa extractinduced blood and immune changes in wistar rats. American Journal of Biochemistry and Biotechnology, 9 (2): 162-171 * Gazali BSA et al (2014) Study level of Interleukin-1? and Interleukin-2 in women infected with Trichomonas vaginalis parasite * Nacar OA et al. (2014) Systemic administration of atorvastatin improves locomotor functions and hyperacute-acute response after experimental spinal cord injury: an ultrastructural and biochemical analysis. Turk Neurosurg. 2014;24(3):337-43. doi: 10.5137/1019-5149.JTN.8131-13.1 * Ahmed HH et al. (2015) Evolving concepts of depression provide new therapeutic options. Journal of Chemical and Pharmaceutical Research. 7(1):435-452 * El-Salam MA et al.(2015) Antimicrobial peptide LL 37 as a novel marker for diagnosis of early onset neonatal sepsis. Merit Res. J. Med. Med. Sci. 3(1):016-021 * Yang X et al. (2016) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ADAMTS-5 AND ADAM17. Patent application:WO2016103042 A1